Related references
Note: Only part of the references are listed.Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Current approaches to the management of brain metastases
John H. Suh et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression
Yi-Ju Chen et al.
CELL (2020)
Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer A Review
Kathryn C. Arbour et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial
Johannes Weller et al.
LANCET ONCOLOGY (2019)
Stereotactic Radiosurgery in the Management of Limited (1-4) Brain Metasteses: Systematic Review and International Stereotactic Radiosurgery Society Practice Guideline
Samuel T. Chao et al.
NEUROSURGERY (2018)
Non-small cell lung cancer brain metastases and the immune system: From brain metastases development to treatment
Elie El Rassy et al.
CANCER TREATMENT REVIEWS (2018)
Whole-Brain Radiotherapy for Brain Metastases: Evolution or Revolution?
Paul D. Brown et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer
J. -C. Soria et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer
Thanyanan Reungwetwattana et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Epidermal Growth Factor Receptor Mutations in Non-Small-Cell Lung Cancer With Brain Metastasis: Can Up-Front Radiation Therapy Be Deferred or Withheld?
Lin Zhou et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naive Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis
William J. Magnuson et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Icotinib versus whole-brain irradiation in patients with EGFR-mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial
Jin-Ji Yang et al.
LANCET RESPIRATORY MEDICINE (2017)
Estimating Survival in Patients With Lung Cancer and Brain Metastases An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
Paul W. Sperduto et al.
JAMA ONCOLOGY (2017)
Brain Metastases from NSCLC: Radiation Therapy in the Era of Targeted Therapies
Jonathan Khalifa et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of central nervous system metastases from non-small cell lung cancer: the present and the future
Claudia Proto et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
EGFR tyrosine kinase inhibitors versus cranial radiation therapy for EGFR mutant non-small cell lung cancer with brain metastases: A systematic review and meta-analysis
Yu Yang Soon et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy
Yin-duo Zeng et al.
ONCOTARGET (2015)
Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases
Stefan Zimmermann et al.
CANCER TREATMENT REVIEWS (2014)
Effect of the Addition of Chemotherapy to Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma: Secondary Analysis of RTOG 98-02
Roshan S. Prabhu et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Randomized Trial of Erlotinib Plus Whole-Brain Radiotherapy for NSCLC Patients With Multiple Brain Metastases
Siow Ming Lee et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study
Masaaki Yamamoto et al.
LANCET ONCOLOGY (2014)
The management of brain metastases in non-small cell lung cancer
Scott Owen et al.
FRONTIERS IN ONCOLOGY (2014)
Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG-0803)
Y. -L. Wu et al.
ANNALS OF ONCOLOGY (2013)
A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Brain Metastases: Radiation Therapy Oncology Group 0320
Paul W. Sperduto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non-Small-Cell Lung Cancer
James W. Welsh et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Rapid increase of serum neuron specific enolase level and tachyphylaxis of EGFR-tyrosine kinase inhibitor indicate small cell lung cancer transformation from EGFR positive lung adenocarcinoma?
Yan Zhang et al.
LUNG CANCER (2013)
Phase II study of whole brain radiotherapy with or without erlotinib in patients with multiple brain metastases from lung adenocarcinoma
Hongqing Zhuang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2013)
Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer
Yosuke Togashi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Lung cancer in never smokers - A review
Sebastien Couraud et al.
EUROPEAN JOURNAL OF CANCER (2012)
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
Paul W. Sperduto et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Tony S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The epidermal growth factor receptor: A role in repair of radiation-induced DNA damage
David J. Chen et al.
CLINICAL CANCER RESEARCH (2007)
Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases - A randomized controlled trial
Hidefumi Aoyama et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Mini-mental status examination: A screening instrument for cognitive and mood disorders of elderly
Arash Mowla et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2006)
Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by Erlotinib (Tarceva)
P Chinnaiyan et al.
CANCER RESEARCH (2005)
Treatment of brain metastases from non-small-cell lung cancer (NSCLC): radiotherapy
A Zabel et al.
LUNG CANCER (2004)
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
DW Andrews et al.
LANCET (2004)
Share Paper
